Cornea Sense is an Aalto University spinout developing next-generation ophthalmic diagnostic technology. The company is developing a medical diagnostic device to help eye doctors diagnose and monitor ophthalmic and metabolic diseases by providing direct and specific ocular surface hydration data.
Investment Rounds
Capital activity and funding progression
Industries
Frequently Asked Questions
Where is Cornea Sense located?
Cornea Sense is located in Espoo, Finland.
What industries does Cornea Sense operate in?
Cornea Sense operates in the following industries: Medical Equipment Manufacturing.
When was Cornea Sense founded?
Cornea Sense was founded on 2026-07-13.
How much total funding has Cornea Sense raised?
Cornea Sense has raised a total of $1,100,000.
Who are the investors in Cornea Sense?
The investors in Cornea Sense are: Innovestor Angel CoFund, Matts Linder, Patrick Aisher, Business Finland.
What is the primary purpose of Cornea Sense?
Cornea Sense is developing a medical diagnostic device designed to help eye doctors diagnose and monitor various eye and metabolic diseases by providing specific, direct data on ocular surface hydration.
How does the technology behind Cornea Sense work?
Cornea Sense utilizes millimeter wave technology to quantify minute changes in corneal tissue water content. By observing how millimeter waves propagate and bounce within the cornea, the device can detect abnormalities earlier than traditional thickness-based measurements.
Why is Cornea Sense focusing on ocular surface hydration?
Many corneal diseases and injuries are linked to abnormal changes in water content. Cornea Sense aims to establish ocular hydration as a new standard in preventive healthcare, enabling earlier diagnosis before complications become severe.
Who is the team behind Cornea Sense?
The Cornea Sense team consists of experts including CEO Anton Chernenko, PhD, CTO Irina Nefedova, PhD, and Product Owner Roman Grigorev, PhD.